Novo Nordisk Aktie
59,12
EUR
-1,76
EUR
-2,89
%
59,42
EUR
-0,58
EUR
-0,97
%
Werbung
Novo Nordisk Aktie Analyse
10.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
10.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
07.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Buy | Deutsche Bank AG | |
06.02.25 | Novo Nordisk Buy | UBS AG | |
06.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
05.02.25 | Novo Nordisk Buy | UBS AG | |
05.02.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
Werbung
|
|||
05.02.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.02.25 | Novo Nordisk Buy | UBS AG | |
29.01.25 | Novo Nordisk Buy | UBS AG | |
29.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.01.25 | Novo Nordisk Buy | UBS AG | |
27.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.01.25 | Novo Nordisk Buy | UBS AG | |
24.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
24.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.01.25 | Novo Nordisk Buy | UBS AG | |
17.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
17.01.25 | Novo Nordisk Buy | UBS AG | |
16.01.25 | Novo Nordisk Buy | UBS AG | |
13.01.25 | Novo Nordisk Buy | UBS AG | |
10.01.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
10.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
08.01.25 | Novo Nordisk Buy | UBS AG | |
06.01.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.01.25 | Novo Nordisk Buy | Deutsche Bank AG | |
23.12.24 | Novo Nordisk Overweight | Barclays Capital | |
17.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
16.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
12.12.24 | Novo Nordisk Buy | Deutsche Bank AG | |
04.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
03.12.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
27.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
27.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
04.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
04.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
01.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
31.10.24 | Novo Nordisk Buy | Deutsche Bank AG | |
30.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
21.10.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. |
Werbung
Werbung